Clinical Trial Update: Post-market Safety and Effectiveness of the CORUS-LX System in Improving Lumbar Interbody Fusion Outcomes [NA]

View source ↗

Summary

This post-market update summarizes safety and effectiveness data for the CORUS-LX System used in lumbar interbody fusion. The trial is ongoing and enrolling by …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease of the Lumbar Spine
• Lumbar Radiculopathy

Drugs mentioned

• CORUS-LX System

Snippet

Sponsor: Providence Medical Technology, Inc. | Conditions: Radiculopathy Lumbar, Degenerative Lumbar Disc Disease | NA | Status: ENROLLING_BY_INVITATION